Opportunity Information: Apply for CDC RFA OE12 120305CONT16
Apply for CDC RFA OE12 120305CONT16
- The HHS-CDC in the health sector is offering a public funding opportunity titled "Provider Education and Public Awareness about Primary Immunodeficiency Disease" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.070.
- This funding opportunity was created on Feb 17, 2016 and posted on Feb 17, 2016.
- Applicants must submit their applications by Apr 15, 2016. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- Eligible applicants include: Others (see text field entitled Additional Information on Eligibility for clarification).
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
The grant opportunity titled "Provider Education and Public Awareness about Primary Immunodeficiency Disease" (Funding Opportunity Number: CDC RFA OE12 120305CONT16) is a continuation funding announcement issued by the U.S. Department of Health and Human Services, Centers for Disease Control and Prevention (HHS-CDC). It is structured as a cooperative agreement, which typically means the CDC expects to have substantial involvement with the recipient during the project period, such as collaboration on planning, technical assistance, and coordination around deliverables. The activity category is health, and it is listed under CFDA 93.070, which is commonly associated with CDC public health program support.
The core focus of this opportunity is improving education for healthcare providers and increasing public awareness related to primary immunodeficiency diseases (PIDs). In practical terms, this type of program is generally aimed at strengthening recognition, understanding, and timely response to conditions where parts of the immune system do not function properly, often leading to recurrent or severe infections and other complications. Emphasis on "provider education" suggests the work is intended to help clinicians and other healthcare professionals identify potential PID warning signs, understand appropriate referral pathways, and improve diagnostic and management practices. The "public awareness" component indicates efforts to inform patients, families, and communities so they can recognize concerning patterns, seek appropriate evaluation, and engage in informed discussions with healthcare professionals.
The announcement is categorized as "Continuation," indicating it is not a brand-new competitive opportunity in the usual sense, but rather support tied to ongoing work under an existing program or prior award. The eligible applicants field is listed as "Others (see text field entitled Additional Information on Eligibility for clarification)," which signals that eligibility is restricted or specialized and would normally be clarified in the full announcement documentation. In many continuation announcements, eligibility may effectively be limited to current recipients or specific organizations already participating in the program, though the exact restriction would be defined in the detailed eligibility section not included in the provided data.
Key administrative details include an original and current closing date of April 15, 2016, and both the posting date and creation date are February 17, 2016. The award ceiling is shown as 0 and the expected number of awards is left blank, which often means those figures were not publicly specified in the summary record or are determined based on continuation funding levels, availability of appropriations, and satisfactory performance of the existing recipient(s). Overall, the opportunity is best understood as CDC-supported continued work to expand and sustain education and awareness activities related to primary immunodeficiency disease, with the cooperative agreement structure signaling active CDC partnership rather than a hands-off grant.
FAQs: Provider Education and Public Awareness about Primary Immunodeficiency Disease (CDC RFA OE12 120305CONT16)
What is the name of this grant opportunity?
The opportunity is titled "Provider Education and Public Awareness about Primary Immunodeficiency Disease".
What is the Funding Opportunity Number (FON)?
The Funding Opportunity Number is CDC RFA OE12 120305CONT16.
Which agency is offering this funding?
This is a federal funding opportunity from the U.S. Department of Health and Human Services (HHS), specifically the Centers for Disease Control and Prevention (CDC).
What type of funding mechanism is this?
This opportunity is structured as a cooperative agreement. That generally means CDC expects to have substantial involvement during the project period, such as collaboration on planning, technical assistance, and coordination around deliverables.
Is this a new competitive grant or a continuation?
It is categorized as a "Continuation" funding announcement. Based on that label, it is tied to ongoing work under an existing program or prior award, rather than a brand-new open competition in the usual sense.
What is the main purpose of this opportunity?
The core focus is to improve education for healthcare providers and increase public awareness related to primary immunodeficiency diseases (PIDs).
What is the activity category for this grant?
The activity category is listed as Health.
What CFDA number is associated with this opportunity?
The opportunity is listed under CFDA 93.070, which is commonly associated with CDC public health program support.
What kinds of activities are implied by "provider education" in this announcement?
Based on the description provided, "provider education" suggests efforts intended to help clinicians and other healthcare professionals strengthen their ability to recognize potential PID warning signs, understand appropriate referral pathways, and improve diagnostic and management practices.
What kinds of activities are implied by "public awareness" in this announcement?
The "public awareness" component indicates efforts to inform patients, families, and communities so they can recognize concerning patterns, seek appropriate evaluation, and engage in informed discussions with healthcare professionals.
What are primary immunodeficiency diseases (PIDs) in the context of this funding?
In practical terms, PIDs are conditions in which parts of the immune system do not function properly. The provided description links these conditions with issues such as recurrent or severe infections and other complications, and the overall goal of the program is to strengthen recognition, understanding, and timely response.
How involved will CDC be if an organization receives this award?
Because this is a cooperative agreement, CDC involvement is expected to be active rather than hands-off. The summary indicates CDC may collaborate on planning, provide technical assistance, and coordinate around deliverables during the project period.
Who is eligible to apply?
The eligible applicants field is listed as "Others (see text field entitled Additional Information on Eligibility for clarification)". That wording signals eligibility is restricted or specialized and would normally be clarified in the full announcement documentation (not provided here).
Does "Continuation" mean eligibility may be limited?
The description notes that in many continuation announcements, eligibility may effectively be limited to current recipients or specific organizations already participating in the program. However, the exact restriction would be defined in the detailed eligibility section, which is not included in the provided information.
What are the key dates for this opportunity?
The posting date and creation date are both February 17, 2016. The original closing date and the current closing date are both April 15, 2016.
Is this opportunity still open?
Based on the provided closing date of April 15, 2016, the opportunity is shown as having closed on that date.
What is the award ceiling for this opportunity?
The award ceiling is shown as 0. The summary notes this often means the funding amount was not publicly specified in the summary record or may be determined based on continuation funding levels, appropriations, and satisfactory performance.
How many awards does CDC expect to make?
The expected number of awards is left blank in the provided summary information. This can happen when award counts are not specified publicly in a summary record or depend on continuation funding decisions.
What does it mean that the award ceiling is 0 and the expected number of awards is blank?
Based on the explanation in the provided text, those fields may be unspecified in the summary record or may be determined later depending on continuation funding levels, availability of appropriations, and the satisfactory performance of existing recipient(s).
What is the overall takeaway about the purpose and structure of this opportunity?
Overall, the opportunity is best understood as CDC-supported continued work to expand and sustain education and awareness activities related to primary immunodeficiency disease, with the cooperative agreement structure indicating active CDC partnership rather than a hands-off grant.
Browse more opportunities from the same agency: HHS-CDC
Browse more opportunities from the same category: Health
Next opportunity: Combating Antibiotic Resistant Bacteria (CARB) Biopharmaceutical Accelerator
Previous opportunity: Expanding Partnerships and Disseminating HIV Prevention Materials to Reduce HIV and other STDs among Adolescents through National Non-Governmental Organizations
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for CDC RFA OE12 120305CONT16
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (CDC RFA OE12 120305CONT16) also looked into and applied for these:
| Funding Opportunity |
|---|
| Cooperative Agreement with the National Center for Disease Control and Public Health (NCDC) of the Republic of Georgia Apply for CDC RFA GH12 1259205CONT16 Funding Number: CDC RFA GH12 1259205CONT16 Agency: HHS-CDC Category: Health Funding Amount: Case Dependent |
| Protecting and Improving Public Health Globally: Building and Strengthening Public Health Impact, Systems, Capacity and Security Apply for CDC RFA GH15 162702CONT16 Funding Number: CDC RFA GH15 162702CONT16 Agency: HHS-CDC Category: Health Funding Amount: Case Dependent |
| Rwandan Rural Sanitation Activity (RRSA) Apply for RFA 696 16 000002 Funding Number: RFA 696 16 000002 Agency: USAID-RWA Category: Health Funding Amount: $10,700,000 |
| Sustaining Influenza Surveillance Networks and Response to Seasonal and Pandemic Influenza by National Health Authorities outside the United States Apply for CDC RFA IP13 130404CONT16 Funding Number: CDC RFA IP13 130404CONT16 Agency: HHS-CDC Category: Health Funding Amount: Case Dependent |
| NIAID SBIR-Technology Transfer Direct Phase II (R44) Apply for RFA AI 16 009 Funding Number: RFA AI 16 009 Agency: HHS-NIH11 Category: Health Funding Amount: Case Dependent |
| Surveillance and Response to Avian and Pandemic Influenza by National Health Authorities outside the United States Apply for CDC RFA IP13 130604CONT16 Funding Number: CDC RFA IP13 130604CONT16 Agency: HHS-CDC Category: Health Funding Amount: Case Dependent |
| Botswana Comprehensive Care and Support for Orphans and Vulnerable Children Apply for RFA 674 16 000004 Funding Number: RFA 674 16 000004 Agency: USAID-SAF Category: Health Funding Amount: $12,300,000 |
| State Oral Disease Prevention Program Apply for CDC RFA DP13 130704CONT16 Funding Number: CDC RFA DP13 130704CONT16 Agency: HHS-CDC Category: Health Funding Amount: Case Dependent |
| Health Department Demonstration Projects to Reduce HIV Infections and Improve Engagement in HIV Medical Care among Men Who Have Sex with Men (MSM) and Transgender Persons Apply for CDC RFA PS15 150602CONT16 Funding Number: CDC RFA PS15 150602CONT16 Agency: HHS-CDC Category: Health Funding Amount: Case Dependent |
| Strengthening a Regional Public Health Surveillance, Capacity and Laboratory Network for Central America with the Secretaria General del Sistema de la Integracion Centroamericana (SG-SICA)/Consejo de Ministros de Salud de Centroamerica (COMISCA) Apply for CDC RFA GH15 160702CONT16 Funding Number: CDC RFA GH15 160702CONT16 Agency: HHS-CDC Category: Health Funding Amount: Case Dependent |
| Institutional Research and Academic Career Development Awards (IRACDA) (K12) Apply for PAR 16 103 Funding Number: PAR 16 103 Agency: HHS-NIH11 Category: Health Funding Amount: Case Dependent |
| Limited Competition: NIGMS Legacy Community-Wide Scientific Resources (R24) Apply for PAR 16 104 Funding Number: PAR 16 104 Agency: HHS-NIH11 Category: Health Funding Amount: Case Dependent |
| Newborn Screening for Severe Combined Immunodeficiency (SCID) Apply for CDC RFA EH15 150402CONT16 Funding Number: CDC RFA EH15 150402CONT16 Agency: HHS-CDC Category: Health Funding Amount: Case Dependent |
| Protecting and Improving Public Health Systems Globally: Building and Strengthening Public Health Impact, Systems, Capacity and Security Apply for CDC RFA GH14 141803CONT16 Funding Number: CDC RFA GH14 141803CONT16 Agency: HHS-CDC Category: Health Funding Amount: Case Dependent |
| Prescription Drug Overdose Prevention for States Apply for CDC RFA CE15 150102CONT16 Funding Number: CDC RFA CE15 150102CONT16 Agency: HHS-CDC Category: Health Funding Amount: Case Dependent |
| Bridges to the Doctorate (R25) Apply for PAR 16 109 Funding Number: PAR 16 109 Agency: HHS-NIH11 Category: Health Funding Amount: $300,000 |
| Bridges to the Baccalaureate (R25) Apply for PAR 16 110 Funding Number: PAR 16 110 Agency: HHS-NIH11 Category: Health Funding Amount: $300,000 |
| Biomarkers for the Lewy Body Dementias (U01) Apply for RFA NS 16 022 Funding Number: RFA NS 16 022 Agency: HHS-NIH11 Category: Health Funding Amount: Case Dependent |
| Sustained Strengthening of Public Health Laboratory, Transfusion Services, and Health Care Worker Infection Control Practices for Ebola Virus Disease in Liberia Apply for CDC RFA GH15 163002CONT16 Funding Number: CDC RFA GH15 163002CONT16 Agency: HHS-CDC Category: Health Funding Amount: Case Dependent |
| To Strengthen Collaboration between CDC and the National TB Controllers and the National Nurse Coalition Project Apply for CDC RFA PS12 120505CONT16 Funding Number: CDC RFA PS12 120505CONT16 Agency: HHS-CDC Category: Health Funding Amount: Case Dependent |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "CDC RFA OE12 120305CONT16", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.